CATEGORY

BA/BE Studies

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike BA/BE Studies.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

BA/BE Studies Market Monitoring Dashboard


Supply Demand

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

BA/BE Studies Industry Benchmarks


Savings Achieved

(in %)

The average annual savings achieved in BA/BE Studies category is 5.40%

Payment Terms

(in days)

The industry average payment terms in BA/BE Studies category for the current quarter is 73.4 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length

SLAs/KPIs

Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk

Sanctions

AMEs

Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    BA/BE Studies Suppliers


    506
    Total Suppliers
    8
    Diverse Suppliers
    73
    Normalized Supplier Rating
    BA/BE Studies Supplier

    Find the right-fit ba/be studies supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Company
    IQVIA HOLDINGS INC.
    Location
    Jackson, Mississipi
    Duns number
    3862211

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    4
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance
    36

    100
    Limited (1)
    ESG Perfomance (/100)
    Environment
    41
    Social
    30
    Governance
    43
    6 Domains Performance (/100)
    Business behaviour
    48
    Human rights
    39
    Community Environment
    31
    Corporate governance
    40
    Human resources
    22
    Security Scorecard
    77

    Threat indicators
    C
    75
    Network Security
    Detecting insecure network settings
    A
    100
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    D
    63
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    C
    70
    Application Security
    Detecting common website application vulnerbilities
    C
    77
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    A
    100
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    D
    60
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    A
    100
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    A
    100
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    A
    100
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    iqvia.com
    Industry average
    Adverse Media Appearances
    Environmental Issues
    0
    Workforce Health Safety Issues
    0
    Product Service Issues
    1
    Human Rights Issues
    0
    Production Supply Chain Issues
    0
    Environmental Non Compliance Flags
    1
    Corruption Issues
    0
    Regulatory Non Compliance Flags
    2
    Fraud Issues
    0
    Labor Health Safety Flags
    0
    Regulatory Issues
    2
    Workforce Disputes
    0
    Sanctions
    0
    esg energy transition
    28
    Discrimination Workforce Rights Issues
    0
    esg controversies critical severity
    No

    BA/BE Studies market report transcript


    BA/BE Studies Global Market Outlook:

    Market Growth: CAGR growth rate: 3–4 percent between 2013 and 2020. 2019 Market Value: $14.5 Billion.

    Market Drivers:

    • High Trial Complexity
    • Patient Recruitment & Retention
    • Regulatory Landscape
    • Cost Reduction
    • Access to specialized Clinical techniques

    Porter's Analysis on BA/BE Studies:

    Supplier Power

    • Several acquisitions by established early phase providers of niche specialists shows the supplier base consolidation,growth in patient pool availability and the growing demand for Phase I studies among pharmaceutical companies
    • Niche specialists compete with established CROs by having access to a focused patient pool and HV studies.
    • However, since they have a smaller client base, their power is comparatively lesser than that of established players

    Barriers to New Entrants

    • Increased regulatory demand, varying regional regulatory compliance, as well as the cost for conducting phase I trials make it more difficult for suppliers to pose competition to large suppliers
    • Niche specialists have a medium level of barrier as they have access to specialists population (e.g. Renal) focusing on a specific therapeutic area

    Intensity of Rivalry

    • Since greater than 50 percent of engagement between pharma and Phase I provider is project based with only around 10 percent strategic in nature, there exists immense competition among the suppliers
    • The suppliers are leveraging market price through competitive discount structure, ability to provide specific patient pool to beat competition

    Threat of Substitutes

    • Specialization, in terms of therapeutic areas, technology, along with bundling of support services will be the key differentiating factors among the suppliers
    • For both established and niche specialists, the patient pool availability and number of CPU beds will be the key differentiator with experience and risk considered along side

    Buyer Power

    • The supplier market consists of multiple suppliers who are able to cater to several big pharmaceutical companies. Pharma companies have a greater choice and ability to switch between suppliers, hence increasing the buyer power